Stock screener

TNYA

Conviction 4HealthcareScan · Thu, Jun 25, 2026
TNYA$0.7189-1.64%
ResistanceSupportVol 14Insider sell
63 bars
3
Vol MA14 2.61M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +200.00%· 3 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Tenaya Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tenayatherapeutics.com ↗
Price0.7189
Change-1.64%
Gap+2.44%
Rel volume0.36×
Avg volume3.11M
Avg $ vol2.35M
SMA 200.7428
SMA 500.7716
SMA 2000.9954
Price vs 50-6.83%
Price vs 200-27.78%
MA stackbearish
50/200 cross—
Supertrenddown · 0.8709
RSI (14)46
MACD hist0.00
MACD crossbull · 1d
Stoch %K / %D42 / 36
ADX (14)11
+DI / −DI21 / 21
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.87%
ADR %7.47%
52w high2.10
52w low0.5500
From 52w high-65.77%
Above 52w low+30.71%
New 52w highNo
SqueezeOff
Bollinger width28.65%
%B0.39
Donchian pos16.09%
Donchian high0.9478
Donchian low0.6750
AVWAP (52w high)0.9415
vs AVWAP high-23.65%
AVWAP (52w low)0.8011
vs AVWAP low-10.26%
OBV trendFlat
Chaikin MF (20)-0.34
Today vs 20d0.36×
Avg vol (14d)2.61M
Avg vol (20d)3.11M
Avg $ vol (20d)2.35M
Market cap156M
RS 3m (vs SPY)-15.76%
RS 6m (vs SPY)-3.40%
RS line new highNo
Trend template1/8
Technical rank30.6
1 week+1.04%
1 month-8.07%
3 months-0.48%
6 months-5.05%
1 year+10.02%
YTD-2.15%
P/E-1.72
P/B1.47
P/S—
P/FCF-2.26
EPS-0.5900
Div yield—
ROE-85.32%
ROA-67.07%
Debt/Eq—
Current5.75
EV/EBITDA-0.88
Gross margin—
Net margin—
Rev growth—
EPS growth18.48%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value75.11M
Revenue225K
Net income-19.27M
Gross profit—
Free cash flow-68.88M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out217M
Employees70
ListedFri, Jul 30, 2021
Free float155.92M
Float %71.9%
Short interest29.3M
Days to cover9.5d
Short volume36.3%
Squeeze score63 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.08 · 4 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank30.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.05
Support0.6767
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TNYA

All disclosures →
No recent disclosed trades by Congress in TNYA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TNYA · 7 buys · 3 sells

InsiderSideShares
Srivastava Deepak
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Williams R Sanders
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Burroughs Amy L.
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Walsh Jeffrey T.
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Lee June
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Parschauer Karah Herdman
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Stehman-Breen Catherine
Director · Stock Option (Right to buy) · 2026-05-28
Grant120K
Higa Tomohiro
SVP, Finance · Common Stock · 2026-05-18
Sell1.49K
Tingley Whittemore
Chief Medical Officer · Common Stock · 2026-05-18
Sell3.12K
Ali Faraz
Chief Executive Officer · Common Stock · 2026-05-18
Sell3.39K

SEC filings

EDGAR filings in TNYA

EDGAR →

No recent SEC filings on file for TNYA.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.